Glück Conviction Score™ ⓘ
JNJ
JOHNSON & JOHNSON
Effektiv: Stark
Sehr hoch
Bedeutung der Einstufung ⓘ
Insider
0,0
Keine Insider-Käufe
Institutionell
90,8
271 neu, 1654 erhöht, 40013,0M $ netto
Aktivist
27,0
Kein 13D/13G
Risikofreier Zins (T-Bills): 3,69% (Stand: 31.05.2026)
Score-Verlauf (90 Tage)
Farbzonen = Stärkestufen (Sehr schwach … Sehr stark). Exit-Score unter der Schwelle = Timing-Ausstieg. Komponenten per Legende einblenden.
Kursverlauf (12 Monate)
Technische Indikatoren
Technical-Score basiert auf 12 Indikatoren (Trend, Momentum, Volatilität, Position) mit fixen Gewichten — wird aktuell nur informativ angezeigt und fließt nicht in den Glück Conviction Score ein. Integration nach Backtest-Kalibrierung (P5).
| Indikator | Signal | Gewicht | Wert | Detail | Beitrag |
|---|---|---|---|---|---|
| Kurs vs SMA50 | Bullisch | 10 % | 230.98 | +4.3 % vs SMA50 | |
| Kurs vs SMA200 | Bullisch | 15 % | 214.60 | +12.2 % vs SMA200 | |
| EMA20 vs EMA50 | Bullisch | 5 % | 231.95 | EMA50: 231.30 | |
| MACD-Histogramm | Bullisch | 10 % | 1.613 | Bullisch | |
| RSI(14) | Neutral | 10 % | 66.1 | Neutral (30–70) | |
| Stoch %K(14) | Bärisch | 5 % | 96.5 | Überkauft | |
| ADX(14)+DI | Neutral | 10 % | 18.5 | +DI: 29.6 / −DI: 17.8 | |
| Z-Score(60) | Neutral | 5 % | 1.30 | In Range | |
| 52W-Position | Bullisch | 5 % | 92.2 % | Hoch 248.56 / Tief 149.79 | |
| Bollinger(20,2σ) | Bärisch | 5 % | 99.9 % | Upper 240.88 / Mid 230.80 / Lower 220.72 | |
| LinReg-Slope(60) | Neutral | 10 % | -0.1837 | R²=0.24 / annualisiert -19.9 % |
Insider-Transaktionen (12 Monate) ⓘ
| Datum | Insider | Rolle | Typ | Stückzahl | Kurs | Wert (USD) | Δ | Trend |
|---|---|---|---|---|---|---|---|---|
| 2026-06-11 | Wengel Kathryn E | Officer, EVP, Chief TO and Risk Officer | Open Market Sale | -10.000 | 241,15 | -2.411.500,00 | -45,9% | |
| 2026-02-27 | Decker Robert J | Officer, VP Corporate Controller | Open Market Sale | -4.075 | 247,87 | -1.010.070,25 | -19,2% | |
| 2026-02-20 | Schmid Timothy | Officer, EVP, WW Chair, MedTech | Open Market Sale | -1.322 | 245,66 | -324.762,52 | -6,2% | |
| 2026-02-18 | Schmid Timothy | Officer, EVP, WW Chair, MedTech | Open Market Sale | -13.625 | 244,20 | -3.327.225,00 | -63,4% | |
| 2026-02-18 | Schmid Timothy | Officer, EVP, WW Chair, MedTech | Open Market Sale | -8.998 | 244,53 | -2.200.280,94 | -41,9% | |
| 2026-02-17 | REED JOHN C | Officer, EVP, Innovative Medicine, R&D | Open Market Sale | -21.721 | 243,00 | -5.278.203,00 | -100,5% | |
| 2026-02-17 | REED JOHN C | Officer, EVP, Innovative Medicine, R&D | Open Market Sale | -2.283 | 243,00 | -554.769,00 | -10,6% | |
| 2026-02-17 | Swanson James D. | Officer, EVP, CIO | Open Market Sale | -20.521 | 242,70 | -4.980.446,70 | -94,8% | |
| 2026-02-17 | Wolk Joseph J | Officer, Exec VP, CFO | Open Market Sale | -12.066 | 242,87 | -2.930.469,42 | -55,8% | |
| 2026-02-17 | Wolk Joseph J | Officer, Exec VP, CFO | Open Market Sale | -19.241 | 242,99 | -4.675.370,59 | -89,0% | |
| 2026-02-17 | Wolk Joseph J | Officer, Exec VP, CFO | Open Market Sale | -24.961 | 242,68 | -6.057.535,48 | -115,4% | |
| 2026-02-17 | Wolk Joseph J | Officer, Exec VP, CFO | Open Market Sale | -33.386 | 242,75 | -8.104.451,50 | -154,3% | |
| 2026-02-17 | Broadhurst Vanessa | Officer, EVP, Global Corp Affairs | Open Market Sale | -6.197 | 243,39 | -1.508.287,83 | -28,7% | |
| 2026-02-17 | REED JOHN C | Officer, EVP, Innovative Medicine, R&D | Open Market Sale | -29.927 | 243,00 | -7.272.261,00 | -138,5% | |
| 2026-02-13 | Swanson James D. | Officer, EVP, CIO | Open Market Sale | -19.368 | 243,76 | -4.721.143,68 | -89,9% | |
| 2026-02-13 | Swanson James D. | Officer, EVP, CIO | Open Market Sale | -22.191 | 243,71 | -5.408.168,61 | -103,0% | |
| 2026-01-26 | Duato Joaquin | Director, Officer, CEO and Chairman of the Board | Open Market Sale | -51.218 | 220,99 | -11.318.460,95 | -215,5% | |
| 2026-01-26 | Duato Joaquin | Director, Officer, CEO and Chairman of the Board | Open Market Sale | -48.782 | 221,48 | -10.804.432,49 | -205,8% | |
| 2025-11-26 | MORIKIS JOHN G | Director | Open Market Purchase | 1.250 | 206,15 | 257.687,50 | +4,9% | |
| 2025-10-17 | REED JOHN C | Officer, EVP, Innovative Medicine, R&D | Open Market Sale | -21.721 | 192,71 | -4.185.793,09 | -79,7% | |
| 2025-09-04 | Taubert Jennifer L | Officer, EVP, WWC. Innovative Medicine | Open Market Sale | -56.471 | 177,81 | -10.040.882,63 | -191,2% | |
| 2025-08-22 | Duato Joaquin | Director, Officer, CEO and Chairman of the Board | Open Market Sale | -125.824 | 179,21 | -22.548.654,81 | -429,4% | |
| 2025-08-15 | Wolk Joseph J | Officer, Exec VP, CFO | Open Market Sale | -16.820 | 176,91 | -2.975.570,69 | -56,7% | |
| 2025-07-17 | REED JOHN C | Officer, EVP, Innovative Medicine, R&D | Open Market Sale | -19.137 | 163,55 | -3.129.829,56 | -59,6% |
Fondsaktivität (Vorquartalsvergleich) ⓘ
| Fonds | Aktuell (Stk) | Vorquartal (Stk) | Veränderung (Stk) | Wert (USD) | Status | Δ | Trend |
|---|---|---|---|---|---|---|---|
| BlackRock, Inc. | 213.385.546 | 208.781.159 | 4.604.387 | 52.159.962.657 | Aufgestockt | +2,2% | |
| VANGUARD GROUP INC | 240.349.660 | 0 | 240.349.660 | 49.740.362.171 | Neu | +100,0% | |
| VANGUARD CAPITAL MANAGEMENT LLC | 156.605.370 | 0 | 156.605.370 | 38.280.616.643 | Neu | +100,0% | |
| STATE STREET CORP | 133.476.288 | 133.869.843 | -393.555 | 32.626.943.839 | Reduziert | -0,3% | |
| GEODE CAPITAL MANAGEMENT, LLC | 59.164.862 | 57.953.747 | 1.211.115 | 14.422.987.278 | Aufgestockt | +2,1% | |
| JPMORGAN CHASE & CO | 59.332.438 | 0 | 59.332.438 | 12.278.848.754 | Neu | +100,0% | |
| MORGAN STANLEY | 44.721.167 | 46.325.589 | -1.604.422 | 10.931.642.638 | Reduziert | -3,5% | |
| STATE FARM MUTUAL AUTOMOBILE INSURANCE CO | 31.590.952 | 31.590.952 | 0 | 7.722.092.307 | Unverändert | 0,0% | |
| NORTHERN TRUST CORP | 29.319.669 | 29.281.433 | 38.236 | 7.166.899.890 | Aufgestockt | +0,1% | |
| NORGES BANK | 33.459.884 | 0 | 33.459.884 | 6.924.522.994 | Neu | +100,0% | |
| BANK OF AMERICA CORP /DE/ | 25.516.697 | 28.333.601 | -2.816.904 | 6.237.301.324 | Reduziert | -9,9% | |
| FMR LLC | 24.771.828 | 18.776.671 | 5.995.157 | 6.055.225.802 | Aufgestockt | +31,9% | |
| WELLINGTON MANAGEMENT GROUP LLP | 20.075.375 | 23.238.388 | -3.163.013 | 4.907.224.664 | Reduziert | -13,6% | |
| UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC | 19.628.113 | 17.275.937 | 2.352.176 | 4.797.895.941 | Aufgestockt | +13,6% | |
| Legal & General Group Plc | 19.347.862 | 18.744.587 | 603.275 | 4.729.391.383 | Aufgestockt | +3,2% | |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 19.177.219 | 19.034.302 | 142.917 | 4.687.813.724 | Aufgestockt | +0,8% | |
| GOLDMAN SACHS GROUP INC | 18.691.347 | 16.628.872 | 2.062.475 | 4.568.912.798 | Aufgestockt | +12,4% | |
| WELLS FARGO & COMPANY/MN | 17.203.554 | 18.523.844 | -1.320.290 | 4.205.236.500 | Reduziert | -7,1% | |
| DIMENSIONAL FUND ADVISORS LP | 15.832.514 | 17.255.149 | -1.422.635 | 3.869.997.385 | Reduziert | -8,2% | |
| Invesco Ltd. | 15.046.905 | 12.725.881 | 2.321.024 | 3.678.065.518 | Aufgestockt | +18,2% | |
| DEUTSCHE BANK AG\ | 14.435.647 | 13.494.166 | 941.481 | 3.528.649.555 | Aufgestockt | +7,0% | |
| ROYAL BANK OF CANADA | 14.012.402 | 14.807.561 | -795.159 | 3.425.192.000 | Reduziert | -5,4% | |
| AMERIPRISE FINANCIAL INC | 13.779.406 | 13.446.440 | 332.966 | 3.369.638.739 | Aufgestockt | +2,5% | |
| MASSACHUSETTS FINANCIAL SERVICES CO /MA/ | 13.434.302 | 16.388.566 | -2.954.264 | 3.317.071.396 | Reduziert | -18,0% | |
| Amundi | 13.406.820 | 11.405.681 | 2.001.139 | 3.277.163.081 | Aufgestockt | +17,5% | |
| Nuveen, LLC | 12.490.455 | 10.609.171 | 1.881.284 | 3.053.166.916 | Aufgestockt | +17,7% | |
| Capital World Investors | 11.749.361 | 9.692.884 | 2.056.477 | 2.872.013.619 | Aufgestockt | +21,2% | |
| UBS Group AG | 11.162.975 | 11.249.735 | -86.760 | 2.728.677.609 | Reduziert | -0,8% | |
| HighTower Advisors, LLC | 10.484.201 | 3.948.748 | 6.535.453 | 2.562.787.080 | Aufgestockt | +165,5% | |
| FRANKLIN RESOURCES INC | 10.474.706 | 10.795.058 | -320.352 | 2.560.436.964 | Reduziert | -3,0% | |
| RAYMOND JAMES FINANCIAL INC | 10.239.939 | 10.359.905 | -119.966 | 2.502.115.061 | Reduziert | -1,2% | |
| Fisher Asset Management, LLC | 9.263.611 | 8.866.207 | 397.404 | 2.264.397.361 | Aufgestockt | +4,5% | |
| HSBC HOLDINGS PLC | 8.892.797 | 9.451.553 | -558.756 | 2.173.177.659 | Reduziert | -5,9% | |
| Capital Research Global Investors | 8.739.988 | 2.869.810 | 5.870.178 | 2.136.397.666 | Aufgestockt | +204,5% | |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 8.704.882 | 9.090.054 | -385.172 | 2.127.821.356 | Reduziert | -4,2% | |
| CITADEL ADVISORS LLC | 8.186.976 | 6.427.202 | 1.759.774 | 2.001.224.413 | Aufgestockt | +27,4% | |
| JANUS HENDERSON GROUP PLC | 7.872.478 | 7.723.981 | 148.497 | 1.924.322.708 | Aufgestockt | +1,9% | |
| GQG Partners LLC | 7.317.289 | 7.752.266 | -434.977 | 1.788.642.935 | Reduziert | -5,6% | |
| Grantham, Mayo, Van Otterloo & Co. LLC | 7.278.866 | 7.089.139 | 189.727 | 1.779.246.370 | Aufgestockt | +2,7% | |
| Swiss National Bank | 7.070.707 | 6.599.607 | 471.100 | 1.728.363.619 | Aufgestockt | +7,1% | |
| JOURNEY STRATEGIC WEALTH LLC | 6.998.885 | 7.052.942 | -54.057 | 1.710.807.535 | Reduziert | -0,8% | |
| BARCLAYS PLC | 6.969.807 | 4.763.661 | 2.206.146 | 1.703.699.625 | Aufgestockt | +46,3% | |
| Ninety One UK Ltd | 6.642.299 | 6.810.748 | -168.449 | 1.623.643.389 | Reduziert | -2,5% | |
| DZ BANK AG Deutsche Zentral Genossenschafts Bank, Frankfurt am Main | 6.172.828 | 2.838.631 | 3.334.197 | 1.508.882.488 | Aufgestockt | +117,5% | |
| CALIFORNIA PUBLIC EMPLOYEES RETIREMENT SYSTEM | 5.994.988 | 7.439.241 | -1.444.253 | 1.465.414.867 | Reduziert | -19,4% | |
| Allianz Asset Management GmbH | 5.900.802 | 6.183.528 | -282.726 | 1.442.392.041 | Reduziert | -4,6% | |
| ALLIANCEBERNSTEIN L.P. | 6.948.656 | 7.695.402 | -746.746 | 1.438.024.359 | Reduziert | -9,7% | |
| PNC FINANCIAL SERVICES GROUP, INC. | 5.752.985 | 5.985.190 | -232.205 | 1.406.259.605 | Reduziert | -3,9% | |
| Sumitomo Mitsui Trust Group, Inc. | 5.660.660 | 5.946.335 | -285.675 | 1.383.691.730 | Reduziert | -4,8% | |
| Mitsubishi UFJ Asset Management Co., Ltd. | 5.654.814 | 5.278.800 | 376.014 | 1.382.257.032 | Aufgestockt | +7,1% |
Top-Fondshalter (Stand: 31.03.2026) ⓘ
| Fonds | Anteile | Vorquartal (Stk) | Δ | Wert (USD) | Anteil (%) |
|---|---|---|---|---|---|
| BlackRock, Inc. | 213.385.546 | 208.781.159 | +2,2% | 52.159.962.657 | 13,03 |
| VANGUARD CAPITAL MANAGEMENT LLC | 156.605.370 | 0 | +100,0% | 38.280.616.643 | 9,57 |
| STATE STREET CORP | 133.476.288 | 133.869.843 | -0,3% | 32.626.943.839 | 8,15 |
| JPMORGAN CHASE & CO | 64.743.944 | 59.332.438 | +9,1% | 15.699.759.532 | 3,92 |
| GEODE CAPITAL MANAGEMENT, LLC | 59.164.862 | 57.953.747 | +2,1% | 14.422.987.278 | 3,60 |
| MORGAN STANLEY | 44.721.167 | 46.325.589 | -3,5% | 10.931.642.638 | 2,73 |
| STATE FARM MUTUAL AUTOMOBILE INSURANCE CO | 31.590.952 | 31.590.952 | 0,0% | 7.722.092.307 | 1,93 |
| NORTHERN TRUST CORP | 29.319.669 | 29.281.433 | +0,1% | 7.166.899.890 | 1,79 |
| BANK OF AMERICA CORP /DE/ | 25.516.697 | 28.333.601 | -9,9% | 6.237.301.324 | 1,56 |
| FMR LLC | 24.771.828 | 18.776.671 | +31,9% | 6.055.225.802 | 1,51 |
| WELLINGTON MANAGEMENT GROUP LLP | 20.075.375 | 23.238.388 | -13,6% | 4.907.224.664 | 1,23 |
| UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC | 19.628.113 | 17.275.937 | +13,6% | 4.797.895.941 | 1,20 |
| Legal & General Group Plc | 19.347.862 | 18.744.587 | +3,2% | 4.729.391.383 | 1,18 |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 19.177.219 | 19.034.302 | +0,8% | 4.687.813.724 | 1,17 |
| GOLDMAN SACHS GROUP INC | 18.691.347 | 16.628.872 | +12,4% | 4.568.912.798 | 1,14 |
| WELLS FARGO & COMPANY/MN | 17.203.554 | 18.523.844 | -7,1% | 4.205.236.500 | 1,05 |
| DIMENSIONAL FUND ADVISORS LP | 15.832.514 | 17.255.149 | -8,2% | 3.869.997.385 | 0,97 |
| Invesco Ltd. | 15.046.905 | 12.725.881 | +18,2% | 3.678.065.518 | 0,92 |
| DEUTSCHE BANK AG\ | 14.435.647 | 13.494.166 | +7,0% | 3.528.649.555 | 0,88 |
| ROYAL BANK OF CANADA | 14.012.402 | 14.807.561 | -5,4% | 3.425.192.000 | 0,86 |
Halter-Trend (6 Quartale)
| Periode | Status | Halter | Anteile (Mio) | Wert (Mio $) |
|---|---|---|---|---|
| 31.03.2026 | ✓ | 4.458 | 1.958,0 | 463.291 |
| 31.12.2025 | ✓ | 4.374 | 1.945,6 | 377.964 |
| 30.09.2025 | ✓ | 4.173 | 1.908,8 | 346.218 |
| 30.06.2025 | ✓ | 4.006 | 1.827,9 | 269.160 |
| 31.03.2025 | ✓ | 4.055 | 1.858,9 | 297.874 |
| 31.12.2024 | ✓ | 3.950 | 1.866,1 | 262.433 |
Top 10 Neueinsteiger
| Fonds | Anteile | Wert (USD) ⓘ |
|---|---|---|
| NORGES BANK | 33.459.884 | 6.924.522.994 |
| Capital World Investors | 9.692.884 | 2.005.942.345 |
| Eurizon Capital SGR S.p.A. | 1.922.990 | 397.818.798 |
| PFA Pension, Forsikringsaktieselskab | 1.488.275 | 307.939.067 |
| GLENMEDE TRUST CO NA | 1.403.321 | 290.417.279 |
| EP Wealth Advisors, LLC | 627.432 | 129.847.038 |
| TUDOR INVESTMENT CORP ET AL | 527.700 | 109.207.515 |
| NOMURA ASSET MANAGEMENT INTERNATIONAL INC. | 502.785 | 104.055.736 |
| Pinnacle Financial Partners, Inc. | 440.493 | 91.165.944 |
| Arrowpoint Investment Partners (Singapore) Pte. Ltd. | 313.929 | 64.967.607 |
Top 10 Aufstocker
| Fonds | Anteile | Δ Anteile ⓘ | Δ % ⓘ | Wert (USD) ⓘ |
|---|---|---|---|---|
| Auto-Owners Insurance Co | 69.419.308 | 69.108.368 | +22225.6 % | 69.419.308 |
| FMR LLC | 18.776.671 | 5.333.244 | +39.7 % | 3.885.832.090 |
| VANGUARD GROUP INC | 240.349.660 | 3.731.074 | +1.6 % | 49.740.362.171 |
| PRICE T ROWE ASSOCIATES INC /MD/ | 12.423.886 | 3.655.754 | +41.7 % | 2.571.124 |
| Capital International Investors | 7.471.031 | 3.605.981 | +93.3 % | 1.546.129.863 |
| GOLDMAN SACHS GROUP INC | 16.628.872 | 3.243.028 | +24.2 % | 3.441.345.139 |
| SG Americas Securities, LLC | 4.019.216 | 2.234.547 | +125.2 % | 378.351 |
| BNP Paribas Asset Management Holding S.A. | 2.385.419 | 1.833.503 | +332.2 % | 493.696 |
| GEODE CAPITAL MANAGEMENT, LLC | 57.953.747 | 1.738.292 | +3.1 % | 11.967.946.703 |
| GQG Partners LLC | 7.752.266 | 1.714.687 | +28.4 % | 1.604.336.241 |
Top 10 Verkäufer
| Fonds | Anteile | Δ Anteile ⓘ | Δ % ⓘ | Wert (USD) ⓘ |
|---|---|---|---|---|
| FRANKLIN RESOURCES INC | 10.795.058 | -5.342.443 | -33.1 % | 2.234.036.933 |
| Assenagon Asset Management S.A. | 1.368.761 | -3.071.786 | -69.2 % | 283.265.089 |
| WELLINGTON MANAGEMENT GROUP LLP | 23.238.388 | -2.594.389 | -10.0 % | 4.809.184.395 |
| DZ BANK AG Deutsche Zentral Genossenschafts Bank, Frankfurt am Main | 2.838.631 | -2.466.905 | -46.5 % | 587.454.951 |
| TWO SIGMA ADVISERS, LP | 350.509 | -1.995.734 | -85.1 % | 72.537.838 |
| JANE STREET GROUP, LLC | 3.483.500 | -1.983.373 | -36.3 % | 720.910.325 |
| Amundi | 11.405.681 | -1.949.255 | -14.6 % | 2.360.405.715 |
| MORGAN STANLEY | 46.325.589 | -1.906.078 | -4.0 % | 9.587.081.210 |
| FLOSSBACH VON STORCH SE | 1.405.626 | -1.589.548 | -53.1 % | 290.894.301 |
| CITADEL ADVISORS LLC | 6.427.202 | -1.565.857 | -19.6 % | 1.330.109.454 |
Aktivisten & Großaktionäre (13D/13G) ⓘ
| Datum | Investor | Typ | Anteil | Aktien | Δ | Zweck |
|---|---|---|---|---|---|---|
| 01.05.2026 | Vanguard Capital Management | Passiv (13G) | 7,49 % | 180.631.228 | Neu | |
| 26.03.2026 | The Vanguard Group | Passiv (13G/A) | Ausstieg | 0 | -10,10 pp | |
| 05.02.2026 | The Vanguard Group | Passiv (13G/A) | 10,10 % | 243.455.135 | +0,57 pp | |
| 30.07.2024 | Johnson & Johnson | Passiv (13G) | 8,80 % | 3.636.363 | Neu | |
| 30.07.2024 | Johnson & Johnson Innovation-JJDC, Inc. | Passiv (13G) | 8,80 % | 3.636.363 | Neu | |
| 13.02.2024 | The Vanguard Group | Passiv (13G/A) | 9,53 % | 229.372.559 | +0,09 pp | |
| 30.01.2024 | : STATE STREET CORPORATION | Passiv (13G/A) | 5,52 % | 0 | +0,07 pp | |
| 26.01.2024 | . BlackRock, Inc. | Passiv (13G/A) | 7,70 % | 186.308.341 | +0,10 pp | |
| 10.02.2023 | : STATE STREET CORPORATION | Passiv (13G/A) | 5,45 % | 0 | -0,06 pp | |
| 09.02.2023 | The Vanguard Group | Passiv (13G/A) | 9,44 % | 246.826.621 | +0,52 pp | |
| 31.01.2023 | . BlackRock, Inc. | Passiv (13G/A) | 7,60 % | 198.802.769 | 0,00 pp | |
| 14.02.2022 | : STATE STREET CORPORATION | Passiv (13G/A) | 5,51 % | 0 | +0,04 pp | |
| 10.02.2022 | The Vanguard Group | Passiv (13G/A) | 8,92 % | 234.782.632 | +0,26 pp | |
| 01.02.2022 | . BlackRock, Inc. | Passiv (13G/A) | 7,60 % | 200.021.352 | +0,40 pp |
US Congress Trades (STOCK Act)
| Datum | Mitglied | Partei | Kammer | Typ | Betrag-Bereich |
|---|---|---|---|---|---|
| 19.03.2026 | John Boozman | – | Senate | Verkauf | $1,001 – $15,000 |
| 10.03.2026 | Lloyd Doggett | – | House | Kauf | $1,001 – $15,000 |
| 18.12.2025 | Julie Johnson | – | House | Verkauf | $1,001 – $15,000 |
| 09.12.2025 | Lloyd Doggett | – | House | Kauf | $1,001 – $15,000 |
| 05.11.2025 | Richard Dean Dr McCormick | – | House | Kauf | $1,001 – $15,000 |
| 31.10.2025 | Lisa McClain | – | House | Verkauf | $1,001 – $15,000 |
| 30.10.2025 | Lisa McClain | – | House | Kauf | $1,001 – $15,000 |
| 30.10.2025 | Lisa McClain | – | House | Verkauf | $1,001 – $15,000 |
| 23.09.2025 | Valerie Hoyle | – | House | Verkauf | $1,001 – $15,000 |
| 04.08.2025 | Lisa McClain | – | House | Kauf | $1,001 – $15,000 |
| 24.06.2025 | Lisa McClain | – | House | Verkauf | $1,001 – $15,000 |
| 17.06.2025 | Lisa McClain | – | House | Kauf | $1,001 – $15,000 |
| 16.06.2025 | Scott Scott Franklin | – | House | Verkauf | $15,001 – $50,000 |
| 12.06.2025 | Pete Sessions | – | House | Verkauf | $15,001 – $50,000 |
| 10.06.2025 | Lloyd Doggett | – | House | Kauf | $1,001 – $15,000 |
| 30.05.2025 | Gilbert Cisneros | – | House | Kauf | $15,001 – $50,000 |
| 12.05.2025 | Jefferson Shreve | – | House | Verkauf | $50,001 – $100,000 |
| 05.05.2025 | Marjorie Taylor Greene | – | House | Kauf | $1,001 – $15,000 |
| 21.04.2025 | Bruce Westerman | – | House | Verkauf | $1,001 – $15,000 |
| 08.04.2025 | Rob Bresnahan | – | House | Verkauf | $1,001 – $15,000 |
| 01.04.2025 | Julie Johnson | – | House | Verkauf | $1,001 – $15,000 |
| 31.03.2025 | Gilbert Cisneros | – | House | Kauf | $15,001 – $50,000 |
| 24.03.2025 | George Whitesides | – | House | Verkauf | $100,001 – $250,000 |
| 19.03.2025 | Sheri Biggs | – | House | Verkauf | $15,001 – $50,000 |
| 05.03.2025 | Jefferson Shreve | – | House | Kauf | $15,001 – $50,000 |
| 04.03.2025 | Lloyd Doggett | – | House | Kauf | $1,001 – $15,000 |
| 03.03.2025 | Bruce Westerman | – | House | Kauf | $1,001 – $15,000 |
| 24.02.2025 | Jefferson Shreve | – | House | Kauf | $15,001 – $50,000 |
| 24.01.2025 | Josh Gottheimer | – | House | Kauf | $1,001 – $15,000 |
| 21.01.2025 | Josh Gottheimer | – | House | Kauf | $1,001 – $15,000 |
| 16.01.2025 | Josh Gottheimer | – | House | Kauf | $1,001 – $15,000 |
| 08.01.2025 | Marjorie Taylor Greene | – | House | Kauf | $1,001 – $15,000 |
| 08.01.2025 | Marjorie Taylor Greene | – | House | Kauf | $1,001 – $15,000 |
| 08.01.2025 | Marjorie Taylor Greene | – | House | Kauf | $1,001 – $15,000 |
| 31.12.2024 | Kevin Hern | – | House | Verkauf | $100,001 – $250,000 |
| 24.12.2024 | Marjorie Taylor Mrs Greene | – | House | Kauf | $1,001 – $15,000 |
| 12.12.2024 | Josh Gottheimer | – | House | Kauf | $1,001 – $15,000 |
| 10.12.2024 | Lloyd Doggett | – | House | Kauf | $1,001 – $15,000 |
| 06.12.2024 | Virginia Foxx | – | House | Kauf | $1,001 – $15,000 |
| 26.11.2024 | Josh Gottheimer | – | House | Kauf | $1,001 – $15,000 |
| 25.11.2024 | Marjorie Taylor Mrs Greene | – | House | Kauf | $1,001 – $15,000 |
| 22.11.2024 | Josh Gottheimer | – | House | Kauf | $1,001 – $15,000 |
| 08.11.2024 | Jared Moskowitz | – | House | Kauf | $1,001 – $15,000 |
| 29.10.2024 | Thomas H Tuberville | – | Senate | Verkauf | $15,001 – $50,000 |
| 29.10.2024 | Valerie Hoyle | – | House | Kauf | $1,001 – $15,000 |
| 26.09.2024 | Ritchie John Torres | – | House | Kauf | $1,001 – $15,000 |
| 10.09.2024 | Lloyd Doggett | – | House | Kauf | $1,001 – $15,000 |
| 04.09.2024 | John James | – | House | Verkauf | $1,001 – $15,000 |
| 07.08.2024 | Scott Scott Franklin | – | House | Kauf | $1,001 – $15,000 |
| 07.08.2024 | C. Scott Franklin | – | House | Kauf | $15,001 – $50,000 |
| 02.08.2024 | C. Scott Franklin | – | House | Kauf | $1,001 – $15,000 |
| 16.07.2024 | Richard W. Allen | – | House | Verkauf | $15,001 – $50,000 |
| 03.07.2024 | Sheldon Whitehouse | – | Senate | Verkauf | $15,001 – $50,000 |
| 03.07.2024 | Sheldon Whitehouse | – | Senate | Verkauf | $15,001 – $50,000 |
| 02.07.2024 | Kathy Manning | – | House | Kauf | $1,001 – $15,000 |
| 02.07.2024 | Kathy Manning | – | House | Kauf | $1,001 – $15,000 |
| 01.07.2024 | Jared Moskowitz | – | House | Kauf | $1,001 – $15,000 |
Quelle: House eFD & Senate eFD (STOCK Act PTR). Betragsangaben sind Bereichsangaben — keine Exaktwerte. Tiefenanalyse für diese Aktie → · Alle Kongress-Bestände →
Stammdaten
Johnson & Johnson forscht und entwickelt, fertigt und verkauft verschiedene Produkte im Gesundheitswesen weltweit, hat jedoch sein Consumer Health Geschäft strategisch 2023 in Kenvue Inc. ausgegliedert, um sich auf seine schneller wachsenden, innovationsgetriebenen Segmente zu konzentrieren; die früheren Consumer Health Marken (darunter TYLENOL, LISTERINE und BAND-AID) befinden sich nun im Besitz von Kenvue. Der aktuelle Fokus des Unternehmens ist nun auf zwei Segmente aufgeteilt: sein Innovative Medicine (ehemals Pharmaceutical) Segment, das Verschreibungsprodukte für komplexe Krankheiten wie rheumatoide Arthritis, verschiedene Krebsarten, HIV/AIDS und neurodegenerative Störungen anbietet; sowie sein MedTech (Medical Devices) Segment, das fortschrittliche Technologielösungen bereitstellt, darunter Elektrophysiologie-Produkte, neurovaskuläre Pflegeprodukte, Orthopädie (Hüften, Knie, Wirbelsäule), fortschrittliche Operationslösungen und Einwegkontaktlinsen unter der Marke ACUVUE. Die zwei verbleibenden Segmente des Unternehmens bedienen hauptsächlich Krankenhäuser, medizinisches Fachpersonal, Großhändler und Einzelhändler und setzen seine Mission fort, die menschliche Gesundheit seit ihrer Gründung 1886 voranzutreiben, und ist gegenwärtig in New Brunswick, New Jersey, ansässig.
Unternehmen & Branche
| Name | JOHNSON & JOHNSON |
|---|---|
| Ticker | JNJ |
| CIK | 0000200406 |
| Boerse | NYSE |
| Sektor | Healthcare |
| Industrie | Drug Manufacturers - General |
| SIC | 2834 · Pharmaceutical Preparations |
Wertpapier & Kennzahlen
| CUSIP | 478160104 |
|---|---|
| ISIN | US4781601046 |
| Typ | Common Stock |
| Marktkapitalisierung | 583,93 Mrd. USD |
| KGV (P/E) | 21,79 |
| Beta | 0,27 |
| Dividendenrendite | 0,00 % |
Bewertung
| KUV (P/S) | 6,20 vs. 5,81 (2022) ▲ |
|---|---|
| FCF-Rendite | 3,4 % vs. 4,3 % (2022) ▼ |
| Buyback-Rendite | 1,0 % vs. 0,8 % (2022) ▲ |
Qualität & Bilanz
| Bruttomarge | 67,9 % vs. 70,3 % (2022) ▼ |
|---|---|
| Nettomarge | 28,5 % vs. 26,5 % (2022) ▲ |
| ROIC | 55,9 % vs. 61,8 % (2022) ▼ |
Basis: SEC-XBRL-Jahresabschluss bis 28.12.2025, Multiples mit aktueller Marktkapitalisierung (trailing), Vergleich: GJ bis 2022. Kennzahlen erklärt →
Kennzahlen-Historie (5 Jahre) – Tabelle & Verlauf
| Kennzahl | 2022 | 2023 | 2023 | 2024 | 2025 | Verlauf |
|---|---|---|---|---|---|---|
| Bewertung | ||||||
| KUV (P/S) | 5,81 | 5,88 | 4,71 | 3,97 | 5,36 | |
| FCF-Rendite | 4,3 % | 3,7 % | 4,5 % | 5,6 % | 3,9 % | |
| Buyback-Rendite | 0,8 % | 1,3 % | 1,3 % | 0,7 % | 1,2 % | |
| Qualität & Bilanz | ||||||
| Bruttomarge | 70,3 % | 69,3 % | 68,8 % | 69,1 % | 67,9 % | |
| Nettomarge | 26,5 % | 22,4 % | 41,3 % | 15,8 % | 28,5 % | |
| ROIC | 61,8 % | 45,2 % | 119,6 % | 38,4 % | 55,9 % | |
Basis: SEC-XBRL-Jahresabschlüsse, Multiples je Geschäftsjahr mit Marktkapitalisierung zum Bilanzstichtag (point-in-time).
Externe Quelle:
SEC EDGAR »
Externe Links: Yahoo Finance » · OnVista »
Finanzkennzahlen (SEC XBRL) ⓘ
| Periode | Filing | Umsatz | Nettoergebnis | EPS | Aktiva | Eigenkapital |
|---|---|---|---|---|---|---|
| 2026-03-29 | 10-Q | 24.062.000.000 | 5.235.000.000 | 2,14 | 200.894.000.000 | 81.186.000.000 |
| 2025-12-31 | 10-K | 94.193.000.000 | 26.804.000.000 | 11,03 | 199.210.000.000 | |
| 2025-12-28 | 10-K | 94.193.000.000 | 26.804.000.000 | 11,03 | 199.210.000.000 | |
| 2025-09-30 | 10-Q | 23.993.000.000 | 5.152.000.000 | 2,12 | 192.816.000.000 | 79.277.000.000 |
| 2025-09-28 | 10-Q | 23.993.000.000 | 5.152.000.000 | 2,12 | 192.816.000.000 | 79.277.000.000 |
| 2025-06-30 | 10-Q | 23.743.000.000 | 5.537.000.000 | 2,29 | 193.389.000.000 | 78.473.000.000 |
| 2025-06-29 | 10-Q | 23.743.000.000 | 5.537.000.000 | 2,29 | 193.389.000.000 | 78.473.000.000 |
| 2025-03-31 | 10-Q | 21.893.000.000 | 10.999.000.000 | 4,54 | 193.671.000.000 | 78.109.000.000 |
| 2025-03-30 | 10-Q | 21.893.000.000 | 10.999.000.000 | 4,54 | 193.671.000.000 | 78.109.000.000 |
| 2024-12-31 | 10-K | 88.821.000.000 | 14.066.000.000 | 5,79 | 180.104.000.000 | |
| 2024-12-29 | 10-K | 88.821.000.000 | 14.066.000.000 | 5,79 | 180.104.000.000 | |
| 2024-09-30 | 10-Q | 22.471.000.000 | 2.694.000.000 | 1,11 | 178.287.000.000 | 70.158.000.000 |
| 2024-09-29 | 10-Q | 22.471.000.000 | 2.694.000.000 | 1,11 | 178.287.000.000 | 70.158.000.000 |
| 2024-06-30 | 10-Q | 22.447.000.000 | 4.686.000.000 | 1,93 | 181.088.000.000 | 71.538.000.000 |
| 2024-03-31 | 10-Q | 21.383.000.000 | 3.255.000.000 | 1,34 | 171.966.000.000 | 70.020.000.000 |
| 2023-12-31 | 10-K | 85.159.000.000 | 35.153.000.000 | 13,72 | 167.558.000.000 | |
| 2023-10-01 | 10-Q | 21.351.000.000 | 26.028.000.000 | 10,21 | 166.061.000.000 | 71.228.000.000 |
| 2023-09-30 | 10-Q | 21.351.000.000 | 26.028.000.000 | 10,21 | 166.061.000.000 | 71.228.000.000 |
| 2023-07-02 | 10-Q | 21.519.000.000 | 5.144.000.000 | 1,96 | 191.686.000.000 | 75.149.000.000 |
| 2023-06-30 | 10-Q | 21.519.000.000 | 5.144.000.000 | 1,96 | 191.686.000.000 | 75.149.000.000 |
Umsatz nach Segmenten & Regionen ⓘ
Geschäftssegmente
| Segment | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | Anteil | Δ | Trend |
|---|---|---|---|---|---|---|---|---|
| Innovative Medicine | 60,4 Mrd. | 57,0 Mrd. | 54,8 Mrd. | 52,6 Mrd. | – | 64,1 % | +6,0% | |
| Med Tech | 33,8 Mrd. | 31,9 Mrd. | 30,4 Mrd. | 27,4 Mrd. | – | 35,9 % | +6,1% | |
| Pharmaceutical | – | – | – | – | 52,1 Mrd. | – | – | |
| Medical Devices | – | – | – | – | 27,1 Mrd. | – | – | |
| Consumer | – | – | – | – | 14,6 Mrd. | – | – |
Regionen
| Region | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | Anteil | Δ | Trend |
|---|---|---|---|---|---|---|---|---|
| US | 53,8 Mrd. | 50,3 Mrd. | 46,4 Mrd. | 42,0 Mrd. | 47,2 Mrd. | 57,1 % | +6,9% | |
| Non Us | 40,4 Mrd. | 38,5 Mrd. | 38,7 Mrd. | 38,0 Mrd. | 46,6 Mrd. | 42,9 % | +5,0% |
Quartalsergebnisse (Earnings) ⓘ
| Quartal | Stichtag | Verkündet | Umsatz | EPS |
|---|---|---|---|---|
| Q1 2026 | 29.03.2026 | 22.04.2026 | 24,1 Mrd. USD | 2,14 |
| Q3 2025 | 28.09.2025 | 22.10.2025 | 24,0 Mrd. USD | 2,12 |
| Q2 2025 | 29.06.2025 | 24.07.2025 | 23,7 Mrd. USD | 2,29 |
| Q1 2025 | 30.03.2025 | 22.04.2026 | 21,9 Mrd. USD | 4,54 |
| Q3 2024 | 29.09.2024 | 22.10.2025 | 22,5 Mrd. USD | 1,11 |
| Q2 2024 | 30.06.2024 | 24.07.2025 | 22,4 Mrd. USD | 1,93 |
| Q1 2024 | 31.03.2024 | 23.04.2025 | 21,4 Mrd. USD | 1,34 |
| 2023 | 01.10.2023 | 23.10.2024 | 21,4 Mrd. USD | 10,21 |
| 2023 | 02.07.2023 | 25.07.2024 | 21,5 Mrd. USD | 1,96 |
Einreichungs-Historie (10-K / 10-Q)
SEC-Einreichungs-Historie der Quartalsberichte (10-Q) und Jahresberichte
(10-K) der letzten sechs Jahre. Die Spalte „Verzögerung" zeigt die
Tage zwischen Berichtsstichtag und tatsächlicher Einreichung.
Suffix /A kennzeichnet nachträgliche Berichtigungen.
| Eingereicht | Form | Berichtsperiode | Verzögerung | |
|---|---|---|---|---|
| 22.04.2026 | 10-Q | – | – | SEC » |
| 11.02.2026 | 10-K | 28.12.2025 | 45 Tage | SEC » |
| 22.10.2025 | 10-Q | 28.09.2025 | 24 Tage | SEC » |
| 24.07.2025 | 10-Q | 29.06.2025 | 25 Tage | SEC » |
| 23.04.2025 | 10-Q | 30.03.2025 | 24 Tage | SEC » |
| 13.02.2025 | 10-K | 29.12.2024 | 46 Tage | SEC » |
| 23.10.2024 | 10-Q | 29.09.2024 | 24 Tage | SEC » |
| 25.07.2024 | 10-Q | 30.06.2024 | 25 Tage | SEC » |
| 01.05.2024 | 10-Q | 31.03.2024 | 31 Tage | SEC » |
| 16.02.2024 | 10-K | 31.12.2023 | 47 Tage | SEC » |
| 27.10.2023 | 10-Q | 01.10.2023 | 26 Tage | SEC » |
| 31.07.2023 | 10-Q | 02.07.2023 | 29 Tage | SEC » |
| 28.04.2023 | 10-Q | 02.04.2023 | 26 Tage | SEC » |
| 16.02.2023 | 10-K | 01.01.2023 | 46 Tage | SEC » |
| 27.10.2022 | 10-Q | 02.10.2022 | 25 Tage | SEC » |
| 29.07.2022 | 10-Q | 03.07.2022 | 26 Tage | SEC » |
| 29.04.2022 | 10-Q | 03.04.2022 | 26 Tage | SEC » |
| 17.02.2022 | 10-K | 02.01.2022 | 46 Tage | SEC » |
| 29.10.2021 | 10-Q | 03.10.2021 | 26 Tage | SEC » |
| 29.07.2021 | 10-Q | 04.07.2021 | 25 Tage | SEC » |
| 30.04.2021 | 10-Q | 04.04.2021 | 26 Tage | SEC » |
| 22.02.2021 | 10-K | 03.01.2021 | 50 Tage | SEC » |
| 23.10.2020 | 10-Q | 27.09.2020 | 26 Tage | SEC » |
| 24.07.2020 | 10-Q | 28.06.2020 | 26 Tage | SEC » |
Filing-Analyse (10-K / 10-Q)
Narrative-Analyse der letzten Quartals-/Jahresberichte durch Claude (nur Coverage-Gruppen-Mitglieder). Keine Anlageberatung — der qualitative Score dient der Einordnung, nicht als Kaufempfehlung; siehe allgemeiner Hinweis am Seitenende.
| Datum | Form | Stimmung | Guidance | Qualitativ | Zusammenfassung | |
|---|---|---|---|---|---|---|
| 11.02.2026 | 10-K | 0,10 | ? | 48,0 | Das vorliegende Filing enthält nur sehr fragmentarische Textauszüge: Die MD&A-Sektion beschränkt sich auf eine Querverweiszeile ohne inhaltl… | |
|
Zusammenfassung: Das vorliegende Filing enthält nur sehr fragmentarische Textauszüge: Die MD&A-Sektion beschränkt sich auf eine Querverweiszeile ohne inhaltliche Substanz, und der Risk-Factors-Abschnitt liefert ausschließlich die Beschreibung der Cybersecurity-Governance-Struktur (CIO, CISO, Board-Oversight via RCSC mit quartalsweisen Updates). Forward-Looking Statements wurden nicht extrahiert. Auf Basis des verfügbaren Materials zeigt Johnson & Johnson eine solide institutionalisierte Cybersecurity-Governance, jedoch fehlt jegliche Guidance sowie das Gros der Risikofaktoren und der operativen Ergebnisdiskussion für eine belastbare Gesamtbewertung. |
||||||
Kritische 8-K Meldungen ⓘ
| Datum | Meldung | Schwere | Filing | Auszug |
|---|---|---|---|---|
| 30.04.2025 | Item 5.02 — Abgang Schlüsselpersonen | HOCH | SEC | 2055 JNJ55 New York Stock Exchange Item 5.02 Departure of Directors or Certain Officers; Election of Directors… |
| 10.09.2024 | Item 5.02 — Abgang Schlüsselpersonen | HOCH | SEC | 2044 JNJ44 New York Stock Exchange Item 5.02 Departure of Directors or Certain Officers; Election of Directors… |
| 05.12.2023 | Item 5.02 — Abgang Schlüsselpersonen | HOCH | SEC | May 2035 JNJ35 New York Stock Exchange Item 5.02(d). Departure of Directors or Certain Officers; Election of Directors… |
| 01.05.2023 | Item 5.02 — Abgang Schlüsselpersonen | HOCH | SEC | 13(a) of the Exchange Act. ☐ Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment… |
| 03.04.2023 | Item 5.02 — Abgang Schlüsselpersonen | HOCH | SEC | e May 2035 JNJ35 New York Stock Exchange Item 5.02 Departure of Directors or Principal Officers; Election of… |
| 15.02.2023 | Item 5.02 — Abgang Schlüsselpersonen | HOCH | SEC | Item 5.02(d). Departure of Directors or Certain Officers; Election of Directors; Appointment of… |
| 14.02.2023 | Item 5.02 — Abgang Schlüsselpersonen | HOCH | SEC | Item 5.02(d). Departure of Directors or Certain Officers; Election of Directors; Appointment of… |
| 01.12.2022 | Item 5.02 — Abgang Schlüsselpersonen | HOCH | SEC | Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers… |
| 29.04.2022 | Item 5.02 — Abgang Schlüsselpersonen | HOCH | SEC | Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers… |
| 16.02.2022 | Item 5.02 — Abgang Schlüsselpersonen | HOCH | SEC | Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers… |
| 06.01.2022 | Item 5.02 — Abgang Schlüsselpersonen | HOCH | SEC | Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers… |
| 12.10.2021 | Item 5.02 — Abgang Schlüsselpersonen | HOCH | SEC | Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers… |
| 20.08.2021 | Item 5.02 — Abgang Schlüsselpersonen | HOCH | SEC | Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers… |
| 03.12.2020 | Item 5.02 — Abgang Schlüsselpersonen | HOCH | SEC | Item 5.02(d). Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers… |
Fail-to-Deliver (6 Monate) ⓘ
| Datum | FTD-Menge | Kurs | Wert (USD) |
|---|---|---|---|
| 2026-05-13 | 161 | 224,26 | 36.106 |
| 2026-05-07 | 5.684 | 224,62 | 1.276.740 |
| 2026-05-04 | 1.842 | 227,19 | 418.484 |
| 2026-04-29 | 2.110 | 227,79 | 480.637 |
| 2026-04-28 | 1.928 | 225,34 | 434.456 |
| 2026-04-24 | 645 | 230,65 | 148.769 |
| 2026-04-20 | 5.900 | 234,18 | 1.381.662 |
| 2026-04-17 | 2.628 | 234,54 | 616.371 |
| 2026-04-15 | 18 | 240,10 | 4.322 |
| 2026-04-14 | 2.419 | 237,96 | 575.625 |
| 2026-04-10 | 150 | 241,31 | 36.197 |
| 2026-04-08 | 15 | 238,41 | 3.576 |
| 2026-04-07 | 1.345 | 240,97 | 324.105 |
| 2026-04-06 | 1.345 | 243,04 | 326.889 |
| 2026-04-02 | 35.878 | 244,12 | 8.758.537 |
| 2026-03-30 | 6.000 | 240,45 | 1.442.700 |
| 2026-03-26 | 7 | 239,93 | 1.680 |
| 2026-03-25 | 240 | 235,27 | 56.465 |
| 2026-03-17 | 75.420 | 243,19 | 18.341.390 |
| 2026-03-16 | 14.639 | 241,52 | 3.535.611 |
| 2026-03-11 | 1.893 | 243,71 | 461.343 |
| 2026-03-10 | 4.909 | 242,59 | 1.190.874 |
| 2026-03-05 | 13 | 245,30 | 3.189 |
| 2026-03-04 | 103.826 | 246,75 | 25.619.066 |
| 2026-03-03 | 221 | 248,56 | 54.932 |
| 2026-03-02 | 800 | 248,43 | 198.744 |
| 2026-02-27 | 20 | 243,47 | 4.869 |
| 2026-02-24 | 4.200 | 245,84 | 1.032.528 |
| 2026-02-23 | 800 | 242,49 | 193.992 |
| 2026-02-13 | 39 | 244,55 | 9.537 |
| 2026-02-02 | 10.444 | 227,25 | 2.373.399 |
| 2026-01-29 | 1.414 | 227,72 | 321.996 |
| 2026-01-26 | 102.273 | 220,14 | 22.514.378 |
| 2026-01-20 | 4.177 | 218,66 | 913.343 |
| 2026-01-13 | 421 | 209,72 | 88.292 |
| 2025-12-26 | 1.012 | 207,78 | 210.273 |
| 2025-12-22 | 599 | 206,37 | 123.616 |
| 2025-12-18 | 187 | 210,33 | 39.332 |
| 2025-12-15 | 700 | 211,58 | 148.106 |